Direxion Daily S&P Biotech Bear 3X ETF (LABD)

Assets	$85.92M
Expense Ratio	1.07%
PE Ratio	n/a
Shares Out	5.31M
Dividend (ttm)	$0.94
Dividend Yield	7.16%
Ex-Dividend Date	Mar 24, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	7,103,271
Open	13.40
Previous Close	13.48
Day's Range	12.65 - 13.40
52-Week Low	12.47
52-Week High	80.69
Beta	-2.44
Holdings	14
Inception Date	May 28, 2015

About LABD

Fund Home Page

The Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is issued by Direxion.

• Asset Class: Equity
• Category: Trading--Inverse Equity
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: LABD
• ETF Provider: Direxion
• Index Tracked: S&P Biotechnology Select Industry

Top 10 Holdings

114.32% of assets

Name	Symbol	Weight
Goldman Finl Sq Trsry Inst 506	n/a	48.59%
Dreyfus Govt Cash Man Ins	n/a	47.57%
Goldman Sachs Fin Gov 465 Institut	n/a	13.32%
Dreyfus Trsry Securities Cash Mgmt	n/a	5.43%
S&P Biotechnology Select Industry Index Swap	n/a	2.10%
Citi Collateral	n/a	-0.00%
S&P Biotechnology Select Industry Index Swap	n/a	-0.22%
Barclays Collateral	n/a	-0.37%
S&P Biotechnology Select Industry Index Swap	n/a	-0.48%
S&P Biotechnology Select Industry Index Swap	n/a	-1.63%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 24, 2026	$0.08539	Mar 31, 2026
Dec 23, 2025	$0.22872	Dec 31, 2025
Sep 23, 2025	$0.260	Sep 30, 2025
Jun 24, 2025	$0.3696	Jul 1, 2025
Mar 25, 2025	$0.5463	Apr 1, 2025
Dec 23, 2024	$1.2639	Dec 31, 2024

Performance

LABD had a total return of -80.94% in the past year, including dividends. Since the fund's inception, the average annual return has been -53.80%.